Sofosbuvir in combination with ribavirin or simeprevir: real-life study of patients with hepatitis C genotype 4

BACKGROUND: The discovery of direct-acting antiviral agents (DAA) is an outstanding achievement of modern medicine in the current century. The current study aimed to explore the effectiveness and safety of two regimens sofosbuvir (SOF) in combination with either ribavirin (RBV) or simeprevir (SMV) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Moneim, Adel, Aboud, Alaa, Abdel-Gabbar, Mohamed, Zanaty, Mohamed I., Elbary, Amr A. Abd, Ramadan, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302204/
https://www.ncbi.nlm.nih.gov/pubmed/30598598
http://dx.doi.org/10.20524/aog.2018.0327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302204/
https://www.ncbi.nlm.nih.gov/pubmed/30598598
http://dx.doi.org/10.20524/aog.2018.0327

Ejemplares similares